Login / Signup

Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis.

Sarah DemortiereAudrey RicoAdil MaaroufClémence BoutiereJean PelletierBertrand Audoin
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2020)
Maintaining natalizumab during the first trimester may reduce the risk of disease reactivation during pregnancy in patients with active MS.
Keyphrases
  • multiple sclerosis
  • white matter
  • preterm birth
  • pregnancy outcomes
  • pregnant women